Loading...

LENZ LENZ THERAPEUTICS INC Expansion Plans 8-K Filing

LNZ

LNZ

LENZ THERAPEUTICS INC

(LENZ)

2025 8-K

Show Summary

Show Summary

Earnings Releases

Financial Update

Financial Results

Financial Results

Clinical Trial Data

Financial Results

FDA Application

Private Placement

Earnings Reports

Press Release and Corporate...

Merger Agreement and Name C...

Merger Agreement

Dividend Announcement

Merger Agreement

Merger Agreement

Merger Agreement

Sublease Agreement

Appointment and Restructuring

Appointment of Director

Resignation of CFO

Earnings Reports

Retention Agreements

Costs Associated with Exit ...

Announcement of Voluntary P...

External Links:

LENZ Therapeutics reported that as of March 31, 2025, it had approximately $194 million in cash and marketable securities, and announced a Commercial Day event on April 15, 2025, to discuss updates on LNZ100's potential approval and launch.

AI Assistant

LENZ THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.